Neogenomics (NEO) Receivables - Other (2017 - 2024)
Neogenomics (NEO) has disclosed Receivables - Other for 8 consecutive years, with $100000.0 as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Receivables - Other rose 170.27% year-over-year to $100000.0, compared with a TTM value of $100000.0 through Dec 2024, up 170.27%, and an annual FY2024 reading of $100000.0, up 170.27% over the prior year.
- Receivables - Other was $100000.0 for Q4 2024 at Neogenomics, down from $236000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $2.9 million in Q3 2022 and bottomed at $37000.0 in Q4 2023.
- Average Receivables - Other over 5 years is $1.4 million, with a median of $1.8 million recorded in 2020.
- The sharpest move saw Receivables - Other skyrocketed 670.94% in 2020, then plummeted 98.08% in 2023.
- Year by year, Receivables - Other stood at $1.9 million in 2020, then dropped by 10.09% to $1.7 million in 2021, then increased by 10.99% to $1.9 million in 2022, then tumbled by 98.08% to $37000.0 in 2023, then soared by 170.27% to $100000.0 in 2024.
- Business Quant data shows Receivables - Other for NEO at $100000.0 in Q4 2024, $236000.0 in Q1 2024, and $37000.0 in Q4 2023.